Telomere length and outcomes in ischaemic heart failure: Data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA)
Journal article
Haver, Vincent G., Leach, Irene Mateo, Kjekshus, John, Fox, Jayne C., Wedel, Hans, Wikstrand, John, de Boer, Rudolf A., van Gilst, Wiek H., McMurray, John J. V., van Veldhuisen, Dirk J. and van der Harst, Pim. (2015). Telomere length and outcomes in ischaemic heart failure: Data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA). European Journal of Heart Failure. 17(3), pp. 313 - 319. https://doi.org/10.1002/ejhf.237
Authors | Haver, Vincent G., Leach, Irene Mateo, Kjekshus, John, Fox, Jayne C., Wedel, Hans, Wikstrand, John, de Boer, Rudolf A., van Gilst, Wiek H., McMurray, John J. V., van Veldhuisen, Dirk J. and van der Harst, Pim |
---|---|
Abstract | Aims: Leucocyte telomere length is considered a marker of biological ageing and has been suggested to be shorter in patients with CAD and heart failure compared with healthy controls. The aim of this study was to determine whether telomere length is associated with clinical outcomes in patients with ischaemic heart failure and whether this association is superior to chronological age as defined by date of birth. Methods and results: We measured leucocyte telomere length in 3275 patients with chronic ischaemic systolic heart failure participating in the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure ( CORONA ) study. The primary composite endpoint was cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke, which occurred in 575 patients during follow-up. We observed a significant association of leucocyte telomere lengths with the primary endpoint ( hazard ratio 1.10; 95% confidence interval 1.01–1.20; P = 0.03 ). However, this observation was not superior to age as defined by date of birth. The neutral effect of rosuvastatin treatment on clinical outcomes was not modified by baseline telomere length. Conclusion: Biological age as defined by leucocyte telomere length was associated with clinical outcomes in patients with ischaemic heart failure, but this association did not add prognostic information above age as defined by date of birth. |
Keywords | leucocyte telomere length; ageing; heart failure; healthy ageing |
Year | 2015 |
Journal | European Journal of Heart Failure |
Journal citation | 17 (3), pp. 313 - 319 |
Publisher | John Wiley & Sons Ltd |
ISSN | 1388-9842 |
Digital Object Identifier (DOI) | https://doi.org/10.1002/ejhf.237 |
Scopus EID | 2-s2.0-84924290020 |
Page range | 313 - 319 |
Research Group | Mary MacKillop Institute for Health Research |
Publisher's version | File Access Level Controlled |
Place of publication | United Kingdom |
https://acuresearchbank.acu.edu.au/item/8v3w8/telomere-length-and-outcomes-in-ischaemic-heart-failure-data-from-the-controlled-rosuvastatin-multinational-trial-in-heart-failure-corona
Restricted files
Publisher's version
109
total views0
total downloads0
views this month0
downloads this month